Chromosomal microarray analysis in prenatal diagnosis: ethical considerations of the Belgian approach
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada
- The clinical significance of small copy number variants in neurodevelopmental disorders
- Exome sequencing in the assessment of congenital malformations in the fetus and neonate
- Exome sequencing as a first-tier test for copy number variant detection: retrospective evaluation and prospective screening in 2418 cases
- Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists
- Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250k SNP array analysis
- Prenatal diagnosis of chromosomal imbalances
- Detection of copy number variants associated with late-onset conditions in ~16 200 pregnancies: parameters for disclosure and pregnancy outcome
- Exome sequencing in patients with antiepileptic drug exposure and complex phenotypes
- Abstracts from 2021 CCMG-CCGM